Nektar Therapeutics
NKTR
NKTR
177 hedge funds and large institutions have $1.91B invested in Nektar Therapeutics in 2016 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 66 increasing their positions, 63 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 176 → 177 (+1)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
177
Holding in Top 10
5
Calls
$3.22M
Puts
$2.6M
Top Buyers
| 1 | +$17.2M | |
| 2 | +$4.29M | |
| 3 | +$3.39M | |
| 4 |
PC
PointState Capital
New York
|
+$2.85M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.73M |
Top Sellers
| 1 | -$25.6M | |
| 2 | -$25.2M | |
| 3 | -$8.54M | |
| 4 |
D.E. Shaw & Co
New York
|
-$8.2M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$4.07M |